Member access

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  UCB SA    UNC   BE0003739530

UCB SA (UNC)

0
Real-time Quote. Real-time Tradegate - 10/24 04:01:45 pm
65.785 EUR   -0.28%
2d ago EXCLUSIVE- ADVENT, AVISTA NEAR DEAL : sources
3d agoUCB SA : quaterly earnings release
09/26 UCB : Acquisition of own shares
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Deutsche Boerse Ag
10/20/2014 10/21/2014 10/22/2014 10/23/2014 10/24/2014 Date
61.95(c) 62.715(c) 64.383(c) 65.97(c) 65.498(c) Last
60 0 80 2 0 Volume
-3.43% +1.23% +2.66% +2.46% -0.72% Change
More quotes
Company
UCB SA is a biopharmaceutical company that engages in the research, development and commercialization of innovative drugs in the fields of central nervous system and immunology disorders.The company focuses on the development of innovative medicines.It sells bio-pharmaceutical products for treating... 
Sector
Pharmaceuticals
Calendar
10/24Earnings Release
Surperformance© rating of UCB SA
Trading Rating : Investor Rating :
More about the company
Chart UCB SA
Duration : Period :
UCB SA Technical Analysis Chart | UNC | BE0003739530 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 3 558 M
EBIT 2014 514 M
Net income 2014 255 M
Debt 2014 1 483 M
Yield 2014 1,60%
Sales 2015 3 820 M
EBIT 2015 652 M
Net income 2015 381 M
Debt 2015 1 337 M
Yield 2015 1,84%
PER 2014 49,70
PER 2015 32,91
EV / Sales 2014 4,05x
EV / Sales 2015 3,73x
Capitalization 12 911 M
More Financials
Latest news on UCB SA
2d ago EXCLUSIVE- ADVENT, AVISTA NEAR DEAL : sources
3d agoUCB SA : quaterly earnings release
10/08 UCB : Georgia Bio and UCB to Host Parkinson's Gala Benefitting the National Park..
09/26 UCB : Acquisition of own shares
09/24 UCB : Patent Application Titled "Systems and Methods for Administering Medicatio..
09/23 Pending 'inversions' that new U.S. Treasury rules may hit
09/17 UCB : Patent Issued for Method for Producing Protein
09/11 Eastman Chemical to buy Taminco for $1.8 bln
09/10 UCB : Patent Application Titled "Pharmaceutical Composition Comprising Rotigotin..
08/05 EXCLUSIVE : Belgium's UCB explores sale of generics unit Kremers Urban - sources
08/01 UCB : Expands Access to Clinical Study Data (Transparency and Sharing)
07/28 Pfizer's need for deal looms larger with earnings report
More news
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF